Anti-Human CD327/SIGLEC6 Antibody (AK06) from ProteoGenix; catalogue ARO-A23188; research use only.
Know who made it. See the evidence. Buy through one marketplace.
A powerful tool for biotech research.
This highly specific antibody targets the CD327/SIGLEC6 protein, which plays a crucial role in immune regulation and cell signaling. By binding to this protein, the AK06 antibody can modulate its activity and provide valuable insights into various biological processes.
The main application of this antibody is in the field of immunology, where it has been extensively used for studying the function of CD327/SIGLEC6 in immune cell development and function. It has also been shown to be effective in detecting and quantifying the expression of this protein in different cell types and tissues.
In addition, the AK06 antibody has been successfully utilized in experimental models to investigate the role of CD327/SIGLEC6 in various diseases, including autoimmune disorders, cancer, and infectious diseases. Its ability to specifically target this protein makes it a valuable tool for understanding the underlying mechanisms of these conditions and potentially developing new therapeutic approaches.
One of the key advantages of the Anti-Human CD327/SIGLEC6 Antibody (AK06) is its high specificity and sensitivity, which allows for accurate and reliable results in a variety of experimental settings. It has also been extensively validated for use in various techniques, including flow cytometry, immunohistochemistry, and Western blotting.
Researchers and scientists looking to study the function and expression of CD327/SIGLEC6 in their experiments can trust the AK06 antibody to deliver accurate and reproducible results. Its use in both basic and clinical research makes it a valuable asset for biotech companies and academic institutions alike.
In summary, the Anti-Human CD327/SIGLEC6 Antibody (AK06) is a highly specific and reliable tool for investigating the role of CD327/SIGLEC6 in various biological processes and diseases. With its proven effectiveness and versatility, it is an essential component for any biotech research targeting this important protein. Order now and take your research to the next level with the AK06 antibody.
ProteoGenix catalogue number ARO-A23188. For research use only.
Target: Sialic acid-binding Ig-like lectin 6, Siglec-6, CD33 antigen-like 1, CDw327, Obesity-binding protein 1, OB-BP1, CD327, SIGLEC6, CD33L, CD33L1, OBBP1; Clonality: Monoclonal Antibody; Reactivity: Human; Applications: ELISA, Flow Cyt.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
